Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8228284 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 6 Pages |
Abstract
Significant late bladder and rectal toxicities from SBRT for prostate cancer are infrequent. PSA relapse-free survival compares favorably with other definitive treatments. The current evidence supports consideration of stereotactic body radiotherapy among the therapeutic options for localized prostate cancer.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Christopher R. Ph.D., M.D., James D. M.D., Harcharan M.D., Joseph C. M.D.,